scholarly journals Thyroid Function in Pregnancy and Its Influences on Maternal and Fetal Outcomes

2014 ◽  
Vol 12 (4) ◽  
Author(s):  
Forough Saki ◽  
Mohammad Hossein Dabbaghmanesh ◽  
Seyede Zahra Ghaemi ◽  
Sedighe Forouhari ◽  
Gholamhossein Ranjbar Omrani ◽  
...  
Keyword(s):  
Thyroid Function ◽  
Fetal Outcomes ◽  
In Pregnancy

scholarly journals THYROID FUNCTION IN PREGNANCY: MATERNAL AND FETAL OUTCOMES WITH HYPOTHYROIDISM AND SUBCLINICAL THYROID DYSFUNCTION

2011 ◽  
Vol 22 (3) ◽  
pp. 169-187
Author(s):  
NEIL K VANES ◽  
JOHN H LAZARUS ◽  
SHIAO-Y CHAN
Keyword(s):  
Thyroid Hormones ◽  
Pregnant Women ◽  
Thyroid Function ◽  
Thyroid Dysfunction ◽  
Thyroid Disorders ◽  
Thyroid Function Tests ◽  
Fetal Outcomes ◽  
Function Tests ◽  
Maternal Wellbeing ◽  
In Pregnancy

Thyroid hormones are important in the development of the fetus and the placenta as well as in maintaining maternal wellbeing. Thyroid disorders are common in the population as a whole, particularly in women, and therefore are common during pregnancy and the puerperium. Biochemical derangement of thyroid function tests are present in approximately 2.5–5% of pregnant women.

scholarly journals Assessment of the Thyroid Function During the Three Trimesters of Pregnancy Among the Egyptian Population

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A849-A850
Author(s):  
Mohamed Fahmy Amara
Keyword(s):  
Thyroid Function ◽  
Thyroid Dysfunction ◽  
Thyroid Stimulating Hormone ◽  
Human Thyroid ◽  
Thyroid Peroxidase ◽  
Sample Population ◽  
Fetal Outcomes ◽  
Cross Sectional ◽  
Significant Difference ◽  
In Pregnancy

Abstract Background: Pregnancy is associated with significant but reversible changes in the thyroid function that might cause maternal and fetal complications. Undetected and untreated thyroid disorders are associated with adverse maternal and fetal outcomes, thus screening is important. There are limited data on the prevalence of newly diagnosed thyroid disease during pregnancy from Egypt. Therefore, this study was designed to evaluate the prevalence of thyroid dysfunction during the three trimesters of pregnancy. Subjects and Methods: This was a cross-sectional study conducted at the antenatal clinic of El-Shatby Maternity Hospital at Alexandria University. The total sample population comprised of 90 pregnant women divided into 30 women for each trimester compared with 30 non- pregnant healthy women regarding thyroid function parameters and thyroid peroxidase antibody (anti - TPO) by using COBAS analyzer measured by the electrochemiluminescence immunoassay “WCLIA” employs monoclonal antibodies specifically directed against human thyroid-stimulating hormone (TSH), free thyroxine (FT4), FT3 and anti TPO. Results: 120 ladies were enrolled for this study aged between 20-45 years excluding subjects with previously diagnosed endocrinal anomalies. There were significant differences between pregnant and non-pregnant females regarding TSH and FT4, but no significant difference regarding FT3 and anti TPO in all trimesters. Conclusion: There is a discrepancy between FT4 & TSH in pregnancy due to the presence of other stimulatory and inhibitory factors in pregnancy, thyroid anomalies increased with the advance in pregnancy, thus screening of TSH and anti TPO is important. Considering the immense impact that maternal thyroid dysfunction has on maternal and fetal outcomes, prompt identification of thyroid dysfunction and its timely treatment is essential.

Graves'DISEASE IN PREGNANCY: TSH RECEPTOR BINDING INHIBITING IMMUNOGLOBULINS AND MATERNAL AND NEONATAL THYROID FUNCTION

1990 ◽  
Vol 32 (2) ◽  
pp. 141-152 ◽  
Author(s):  
ROBIN H. MORTIMER ◽  
SHIRLEY A. TYACK ◽  
JOHN P. GALLIGAN ◽  
DONALD A. PERRY-KEENE ◽  
YONG M. TAN
Keyword(s):  
Thyroid Function ◽  
Receptor Binding ◽  
Tsh Receptor ◽  
Neonatal Thyroid Function ◽  
In Pregnancy

scholarly journals Relationship between coronavirus disease 2019 in pregnancy and maternal and fetal outcomes: retrospective analytical cohort study

Midwifery ◽  
2021 ◽  
pp. 103128
Author(s):  
Zahra Alipour ◽  
Parisa Samadi ◽  
Narges Eskandari ◽  
Maryam Ghaedrahmati ◽  
Mostafa Vahedian ◽  
...  
Keyword(s):  
Cohort Study ◽  
Fetal Outcomes ◽  
In Pregnancy

scholarly journals Management of thyroid disease in pregnancy – Room for improvement in the first trimester

2016 ◽  
Vol 9 (3) ◽  
pp. 126-129 ◽  
Author(s):  
Helen Robinson ◽  
Philip Robinson ◽  
Michael D’Emden ◽  
Kassam Mahomed
Keyword(s):  
General Practitioner ◽  
Thyroid Function ◽  
Thyroid Disease ◽  
Thyroid Dysfunction ◽  
First Trimester ◽  
Antenatal Clinic ◽  
Thyroid Stimulating Hormone ◽  
Thyroid Function Tests ◽  
In Pregnancy ◽  
Stimulating Hormone

Background First-trimester care of maternal thyroid dysfunction has previously been shown to be poor. This study evaluates early management of thyroid dysfunction in pregnancy in Australia. Methods Patients reviewed by the Obstetric Medicine team for thyroid dysfunction from 1 January 2012 to 30 June 2013 were included. Data were collected on gestation at referral from the patient’s general practitioner to the antenatal clinic, information provided in the referral letter, thyroid function tests and thyroid medications. Results Eighty-five women were included in the study. At the time of general practitioner referral to antenatal services, 19% of women with preexisting thyroid disease had no thyroid function tested. Forty-three percent had an abnormal thyroid-stimulating hormone defined as being outside the laboratory-specific pregnancy reference range if available, or outside the level of 0.1–2.5 mIu/L in the first trimester, 0.2–3.0 mIu/L in the second trimester and 0.3–3.0 mIu/L in the third trimester. Only 21% of women increased their thyroxine dose prior to their first antenatal clinic review. Conclusion This study highlights that a significant proportion of women with known thyroid disease either have untested thyroid function in the first trimester or a thyroid-stimulating hormone outside of levels recommended by guidelines.

scholarly journals Neurocysticercosis in pregnancy: maternal and fetal outcomes

2016 ◽  
Vol 2016 (7) ◽  
pp. 138-140 ◽  
Author(s):  
Rebecca F. D'Cruz ◽  
Sher M. Ng ◽  
Pooja Dassan
Keyword(s):  
Fetal Outcomes ◽  
In Pregnancy

scholarly journals Glanzmann thrombasthenia in pregnancy: Optimising maternal and fetal outcomes

2016 ◽  
Vol 9 (4) ◽  
pp. 169-170 ◽  
Author(s):  
A Wijemanne ◽  
I Watt-Coote ◽  
S Austin
Keyword(s):  
Intracranial Haemorrhage ◽  
Autosomal Recessive ◽  
Postpartum Haemorrhage ◽  
Multidisciplinary Care ◽  
Maternal Outcomes ◽  
Fetal Outcomes ◽  
Glanzmann Thrombasthenia ◽  
Neonatal Complications ◽  
Alloimmune Thrombocytopenia ◽  
In Pregnancy

Glanzmann thrombasthenia is a rare autosomal recessive haemorrhagic disorder. The risks of miscarriage, antepartum and postpartum haemorrhage, and neonatal complications are all increased in individuals presenting with the disease in pregnancy. Some individuals may develop antibodies to platelet glycoproteins; the presence of these antibodies is a rare cause of neonatal alloimmune thrombocytopenia and potential intracranial haemorrhage. Multidisciplinary care is paramount for ensuring optimal fetal and maternal outcomes in such cases. We report a case of neonatal alloimmune thrombocytopenia secondary to maternal Glanzmann thrombasthenia in pregnancy.

scholarly journals Maternal and fetal outcomes in rheumatic heart disease in pregnancy

2014 ◽  
Vol 2 (4) ◽  
pp. 1632
Author(s):  
Dhivya Sethuraman ◽  
Nirmala Ramachandran ◽  
SAP Noorjahan ◽  
Vijay Kanna
Keyword(s):  
Heart Disease ◽  
Rheumatic Heart Disease ◽  
Fetal Outcomes ◽  
Heart Disease In Pregnancy ◽  
Rheumatic Heart ◽  
In Pregnancy

scholarly journals Fetal Outcomes of Anti-epileptic Drug Use in Pregnancy: Teratologic Approach

2021 ◽  
Vol 27 (1) ◽  
pp. 27-33
Author(s):  
Aysel Kalaycı Yiğin ◽  
Mustafa Tarık Alay ◽  
Mehmet Seven
Keyword(s):  
Drug Use ◽  
Fetal Outcomes ◽  
Anti Epileptic Drug ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document